Form 4: Medtronic Executive Matthew R. Walter Reports Stock Transactions

Matthew R. Walter, SVP and Chief HR Officer of Medtronic, reports the acquisition and disposal of ordinary shares related to performance share units.

Summary

• On August 2, 2024, Matthew R. Walter, SVP and Chief HR Officer of Medtronic, engaged in transactions involving Medtronic plc ordinary shares.
• Walter acquired 684 ordinary shares upon the settlement of performance-vesting restricted stock units granted on August 2, 2021.
• He also disposed of 210 shares at $81.51 per share and 231 shares at $81.51 per share to cover tax obligations related to the vesting of restricted stock units.
• Following these transactions, Walter beneficially owns 25,448 ordinary shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation. The vesting of performance share units is a positive sign, but the sale of shares for tax obligations is a neutral event.

Positives

• The vesting of performance share units indicates that performance targets were met, which is a positive signal.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Executive compensation packages often include performance-based equity awards, such as performance share units and restricted stock units, to align management's interests with those of shareholders.
• The vesting and subsequent sale of shares to cover tax obligations are standard practices in executive compensation.
• Comparable companies such as Johnson & Johnson (JNJ) and Abbott Laboratories (ABT) also utilize similar equity-based compensation strategies for their executives.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders.
• The vesting of performance share units suggests that company performance is aligned with the goals set out in the compensation plan, which is a positive signal for shareholders.

Key Dates